Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
Current Pharmaceutical Design
|
June 22, 2006
Cellular entry of HIV: Evaluation of therapeutic targets
Stefan Pöhlmann, Jacqueline D Reeves
The Journal of General Virology
|
May 25, 2002
Human immunodeficiency virus type 2
Jacqueline D Reeves, Robert W Doms
Drugs
|
August 24, 2005
Emerging drug targets for antiretroviral therapy
Jacqueline D Reeves, Andrew J Piefer
Journal of Virology
|
June 15, 2004
Modulation of Env content in virions of simian immunodeficiency virus: correlation with cell surface expression and virion infectivity
Eloísa Yuste, Jacqueline D Reeves, Robert W Doms, et al.
Clinical Liver Disease
|
April 17, 2019
Novel NS5B Resistance-Associated Substitution Emerges Under Failing Sofosbuvir/Ledipasvir Therapy
Lisa Catalli, Sharon K Martens, Norah A Terrault, et al.
Virology
|
November 6, 2003
Evolution of coreceptor use and CD4-independence in envelope clones derived from SIVsm-infected macaques
Dalma Vödrös, Rigmor Thorstensson, Robert W Doms, et al.
Retrovirology
|
December 6, 2006
Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion
Stephen A Gallo, Jacqueline D Reeves, Himanshu Garg, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 11, 2004
Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry
Graham Simmons, Jacqueline D Reeves, Andrew J Rennekamp, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 6, 2005
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
Graham Simmons, Dhaval N Gosalia, Andrew J Rennekamp, et al.
Journal of Virology
|
May 18, 2007
Conserved changes in envelope function during human immunodeficiency virus type 1 coreceptor switching
Cristina Pastore, Rebecca Nedellec, Alejandra Ramos, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
Current Pharmaceutical Design
|
June 22, 2006
Cellular entry of HIV: Evaluation of therapeutic targets
Stefan Pöhlmann, Jacqueline D Reeves
The Journal of General Virology
|
May 25, 2002
Human immunodeficiency virus type 2
Jacqueline D Reeves, Robert W Doms
Drugs
|
August 24, 2005
Emerging drug targets for antiretroviral therapy
Jacqueline D Reeves, Andrew J Piefer
Journal of Virology
|
June 15, 2004
Modulation of Env content in virions of simian immunodeficiency virus: correlation with cell surface expression and virion infectivity
Eloísa Yuste, Jacqueline D Reeves, Robert W Doms, et al.
Clinical Liver Disease
|
April 17, 2019
Novel NS5B Resistance-Associated Substitution Emerges Under Failing Sofosbuvir/Ledipasvir Therapy
Lisa Catalli, Sharon K Martens, Norah A Terrault, et al.
Virology
|
November 6, 2003
Evolution of coreceptor use and CD4-independence in envelope clones derived from SIVsm-infected macaques
Dalma Vödrös, Rigmor Thorstensson, Robert W Doms, et al.
Retrovirology
|
December 6, 2006
Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion
Stephen A Gallo, Jacqueline D Reeves, Himanshu Garg, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 11, 2004
Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry
Graham Simmons, Jacqueline D Reeves, Andrew J Rennekamp, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 6, 2005
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
Graham Simmons, Dhaval N Gosalia, Andrew J Rennekamp, et al.
Journal of Virology
|
May 18, 2007
Conserved changes in envelope function during human immunodeficiency virus type 1 coreceptor switching
Cristina Pastore, Rebecca Nedellec, Alejandra Ramos, et al.
Page
of 5